advertisement

---

Pharmaceutics 10

Showing records 1 to 10 | Display all abstracts in Pharmaceutics

92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Abdelmonem R
Pharmaceutics 2021; 13:

---

92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
Garcia-Herranz D; Rodrigo MJ
Pharmaceutics 2021; 13:

---

92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Elhabal SF
Pharmaceutics 2021; 13:

---

92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
Rodrigo MJ; Subias M; Subias M
Pharmaceutics 2021; 13:

---

92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Abdelmalak NS
Pharmaceutics 2021; 13:

---

92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
Martinez-Rincon T
Pharmaceutics 2021; 13:

---

92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
El-Nabarawi MA
Pharmaceutics 2021; 13:

---

92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
Martinez-Rincon T; Mendez-Martinez S; Mendez-Martinez S
Pharmaceutics 2021; 13:

---

92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Teaima MH
Pharmaceutics 2021; 13:

---

92748 Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal Degeneration
Bravo-Osuna I; Bonet A; Ruberte J; Garcia-Feijoo J; Pablo L; Garcia-Martin E; Herrero-Vanrell R
Pharmaceutics 2021; 13:

---